Recent News

Share
and/or
Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
60 News Items found
In the Lab
MSK scientists Charles Rudin and John Poirier
Scientists Home in on Treatment Advance for Chemotherapy-Resistant Small Cell Lung Cancer

An epigenetic mechanism may make small cell lung cancer vulnerable to a new kind of attack.
Feature
T cells on the loose.
T Is for T Cell: The Science Behind Immunotherapy

By deciphering the biology of T cells, MSK scientists gave immunotherapy a boost.
In the Lab
A chess match
Resistance Is Futile: Targeted Treatment Makes Stubborn Cancers Responsive to Immunotherapy

New research on an experimental drug provides hope for better responses to immunotherapy.
Announcement
Dr. Joan Massagué, Sloan Kettering Institute Director received the Pezcoller Foundation-AACR International Award for Cancer Research and was named an AACR fellow at AACR16.
News from #AACR16: Targeted Therapy Breakthrough, Improved Survival in Melanoma, and Benefits of Gut Bugs

Long-awaited results of clinical trials testing targeted drugs and immunotherapy combinations were on offer at the annual American Association for Cancer Research (AACR) conference.
In the Lab
a sneaky man on a sneaky mission
Stealth Mode: How Metastatic Cancer Cells Evade Detection by the Immune System

Cancer cells have a sneaky ability to hide out in the body for years at a time. MSK scientists are looking for ways to flush them out.
In the Lab
photo of Foxo1 protein stained in regulatory T cells
In the Fight against Cancer, the Immune System Can Be a Double-Edged Sword

The immune system is a powerful tool for fighting cancer — sometimes too powerful.
In the Lab
Light micrograph of white blood cells from a patient with acute myeloid leukemia.
New Drug Developed at MSK Starves Acute Myeloid Leukemia of a Signaling Fix

An innovative collaboration between basic scientists and clinical researchers has led to a promising new drug for AML.
Feature
Microscopic image of spherical cluster of cells, most of them pink cells with a smaller number of blue ones.
Three Compelling Cancer Advances from 2015

MSK researchers moved cancer science ahead in 2015 with landmark discoveries that suggest new treatment strategies and shed light on how the disease progresses.
In the Clinic
Hyperpolarized MRI
Hyperpolarized MRI: A New Tool to Assess Treatment Response within Days

Hyperpolarized MRI could allow doctors to get a read on a tumor’s response to treatment quickly.
In the Lab
MSK investigators Joan Massagué and Anna Obenauf
Outsmarting Cancer’s Survival Skills

A new study led by MSK investigators reveals how some cancer cells become resistant to targeted treatment and suggests what might be done to stop that from happening.